Priced: Carlyle CBAM 2021-14 $431.35M CLO reset via Nomura
On September 02, 2025, Carlyle Group's Collateralized Loan Obligation (CLO) CBAM 2021-14, priced at $431.35 million, has been reset via Nomura Holdings Inc. This transaction, which involves a significant reduction in Nomura's holding in EHang Holdings Limited Unsponsored ADR (NASDAQ: EH), reflects a strategic shift in the institutional investor's portfolio. As of the latest SEC filing, Nomura's position in EHang has decreased by 62.3%, leaving the fund with approximately 0.13% of EHang's stock worth $1,996,000 [1].
This reset comes amid a broader trend of institutional investors adjusting their stakes in EHang. During the first quarter, various funds such as ABS Direct Equity Fund LLC, Schonfeld Strategic Advisors LLC, and Penserra Capital Management LLC acquired new positions in EHang, while others like Tower Research Capital LLC increased their stakes in the fourth quarter [1]. These moves underscore a growing interest in EHang's autonomous aerial vehicle (AAV) technology platform, which operates in passenger transportation, logistics, and smart city management.
Analysts maintain a consensus rating of "Buy" on EHang, with target prices set by firms like JPMorgan ($26.00) and Bank of America ($24.00). The stock has experienced recent price volatility, opening at $15.58 on Wednesday, September 02, 2025, with a market cap of $1.12 billion and a P/E ratio of -31.16 [1]. Despite this volatility, EHang's strong fundamentals and growth prospects continue to attract institutional investors.
In conclusion, Carlyle Group's CLO reset via Nomura represents a strategic realignment in institutional holdings, reflecting broader market dynamics and investor sentiment towards EHang. As the company continues to expand its AAV technology platform, investors should closely monitor its financial performance and analyst ratings for further insights.
References:
[1] https://www.marketbeat.com/instant-alerts/filing-nomura-holdings-inc-has-2-million-position-in-ehang-holdings-limited-unsponsored-adr-eh-2025-09-03/
Comments
No comments yet